Although current evidence points to potential functional redundancy between FAT1 and FAT3 in multiple cancer types, isoform-specific CRISPR or combinatorial siRNA experiments, especially in CC cell lines, are still lacking to quantify their individual contributions to YAP1 nuclear-cytoplasmic shuttling. The gene discussed is FAT1; the disease is cancer.